{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:56:38Z","timestamp":1774522598361,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32230047"],"award-info":[{"award-number":["32230047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02728-z","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:16:18Z","timestamp":1771402578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycogen synthase 1 promotes breast cancer progression by promoting I\u03baB\u03b1 ubiquitination and degradation independent of its canonical enzyme function"],"prefix":"10.1186","volume":"24","author":[{"given":"Shixuan","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2728_CR1","doi-asserted-by":"crossref","unstructured":"Atlas SJ. A global perspective to improving mammogram completion among women overdue for breast cancer screening. JAMA Intern Med. 2026;186:35\u20136.","DOI":"10.1001\/jamainternmed.2025.5883"},{"issue":"1","key":"2728_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","volume":"22","author":"F Ye","year":"2023","unstructured":"Ye F, et al. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer. 2023;22(1):105.","journal-title":"Mol Cancer"},{"issue":"3","key":"2728_CR3","doi-asserted-by":"publisher","first-page":"e0319183","DOI":"10.1371\/journal.pone.0319183","volume":"20","author":"MS Ali","year":"2025","unstructured":"Ali MS. Multilevel analysis of undergoing clinical breast examination and its associated factors among mothers of reproductive age in Kenya: Kenyan Demographic and Health Survey 2022. PLoS ONE. 2025;20(3):e0319183.","journal-title":"PLoS ONE"},{"key":"2728_CR4","doi-asserted-by":"crossref","unstructured":"Chuang HY, Huang YW, Yang H. Dendrimer gel nanoparticles with dual-targeting of upar and ribonucleotide reductase r2 influence necrosis, apoptosis, and cell cycle arrest in triple-negative breast cancer. Mol Pharm. 2025;22:7620\u20139.","DOI":"10.1021\/acs.molpharmaceut.5c01209"},{"issue":"1","key":"2728_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"key":"2728_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"2728_CR7","doi-asserted-by":"publisher","first-page":"E696","DOI":"10.1152\/ajpendo.00074.2024","volume":"326","author":"S Zhuo","year":"2024","unstructured":"Zhuo S, et al. Glycogen synthesis is required for adaptive thermogenesis in beige adipose tissue and affects diet-induced obesity. Am J Physiol Endocrinol Metab. 2024;326(5):E696\u2013708.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7884","key":"2728_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-04019-8","volume":"599","author":"O Keinan","year":"2021","unstructured":"Keinan O, et al. Glycogen metabolism links glucose homeostasis to thermogenesis in adipocytes. Nature. 2021;599(7884):296\u2013301.","journal-title":"Nature"},{"issue":"1","key":"2728_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-020-15636-8","volume":"11","author":"J Ma","year":"2020","unstructured":"Ma J, et al. Glycogen metabolism regulates macrophage-mediated acute inflammatory responses. Nat Commun. 2020;11(1):1769.","journal-title":"Nat Commun"},{"issue":"20","key":"2728_CR10","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.7150\/thno.46825","volume":"10","author":"SL Chen","year":"2020","unstructured":"Chen SL, et al. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-kappaB pathway in Clear Cell Renal Carcinoma. Theranostics. 2020;10(20):9186\u201399.","journal-title":"Theranostics"},{"key":"2728_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2016.04.009","volume":"164","author":"C Wigerup","year":"2016","unstructured":"Wigerup C, Pahlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152\u201369.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"2728_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cmet.2012.10.017","volume":"16","author":"E Favaro","year":"2012","unstructured":"Favaro E, et al. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. Cell Metab. 2012;16(6):751\u201364.","journal-title":"Cell Metab"},{"issue":"8","key":"2728_CR13","doi-asserted-by":"publisher","first-page":"e0135356","DOI":"10.1371\/journal.pone.0135356","volume":"10","author":"Q Matthews","year":"2015","unstructured":"Matthews Q, et al. Radiation-induced glycogen accumulation detected by single cell Raman spectroscopy is associated with radioresistance that can be reversed by metformin. PLoS ONE. 2015;10(8):e0135356.","journal-title":"PLoS ONE"},{"issue":"1","key":"2728_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13046-023-02715-z","volume":"42","author":"EC de Heer","year":"2023","unstructured":"de Heer EC, et al. Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. J Exp Clin Cancer Res. 2023;42(1):143.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2728_CR15","first-page":"523","volume":"38","author":"P Su","year":"2016","unstructured":"Su P, Feng SS, Li QW. Research progress of the structure and function of NF-kappaB and IkappaB in different animal groups. Yi Chuan. 2016;38(6):523\u201331.","journal-title":"Yi Chuan"},{"issue":"2","key":"2728_CR16","first-page":"172","volume":"19","author":"X Tang","year":"2018","unstructured":"Tang X, et al. RUNX1: a regulator of NF-kB signaling in pulmonary diseases. Curr Protein Pept Sci. 2018;19(2):172\u20138.","journal-title":"Curr Protein Pept Sci"},{"issue":"6","key":"2728_CR17","doi-asserted-by":"publisher","first-page":"tfaf152","DOI":"10.1093\/toxres\/tfaf152","volume":"14","author":"J Jiang","year":"2025","unstructured":"Jiang J, et al. Arsenic-induced circFNDC3B regulates apoptosis through dysregulation of NF-kappaB Signaling. Toxicol Res (Camb). 2025;14(6):tfaf152.","journal-title":"Toxicol Res (Camb)"},{"issue":"1","key":"2728_CR18","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1186\/s12885-025-15091-y","volume":"25","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang J, Ren G. UHRF1 and NF-kappaB signaling in prostate cancer progression insights from bioinformatics and experimental validation. BMC Cancer. 2025;25(1):1697.","journal-title":"BMC Cancer"},{"issue":"1","key":"2728_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","volume":"246","author":"SC Sun","year":"2012","unstructured":"Sun SC. The noncanonical NF-kappaB pathway. Immunol Rev. 2012;246(1):125\u201340.","journal-title":"Immunol Rev"},{"issue":"1","key":"2728_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.","journal-title":"Signal Transduct Target Ther"},{"issue":"730","key":"2728_CR21","doi-asserted-by":"publisher","first-page":"eadf1691","DOI":"10.1126\/scitranslmed.adf1691","volume":"16","author":"JC Ullman","year":"2024","unstructured":"Ullman JC, et al. Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders. Sci Transl Med. 2024;16(730):eadf1691.","journal-title":"Sci Transl Med"},{"key":"2728_CR22","doi-asserted-by":"publisher","first-page":"627464","DOI":"10.3389\/fgene.2021.627464","volume":"12","author":"Q Yang","year":"2021","unstructured":"Yang Q, et al. Knockdown of RIPK2 inhibits proliferation and migration, and induces apoptosis via the NF-kappaB signaling pathway in gastric cancer. Front Genet. 2021;12:627464.","journal-title":"Front Genet"},{"issue":"3","key":"2728_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2174\/1871520622666220324100510","volume":"23","author":"J Sun","year":"2023","unstructured":"Sun J, et al. Peimine inhibits MCF-7 breast cancer cell growth by modulating inflammasome activation: critical roles of MAPK and NF-kappaB signaling. Anticancer Agents Med Chem. 2023;23(3):317\u201327.","journal-title":"Anticancer Agents Med Chem"},{"issue":"4","key":"2728_CR24","first-page":"1329","volume":"42","author":"J Li","year":"2019","unstructured":"Li J, et al. SMC1 promotes proliferation and inhibits apoptosis through the NF-kappaB signaling pathway in colorectal cancer. Oncol Rep. 2019;42(4):1329\u201342.","journal-title":"Oncol Rep"},{"issue":"3","key":"2728_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1101\/gad.13.3.284","volume":"13","author":"E Spencer","year":"1999","unstructured":"Spencer E, Jiang J, Chen ZJ. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb\/beta-TrCP. Genes Dev. 1999;13(3):284\u201394.","journal-title":"Genes Dev"},{"issue":"11","key":"2728_CR26","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1093\/emboj\/19.11.2580","volume":"19","author":"A Orian","year":"2000","unstructured":"Orian A, et al. SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase. EMBO J. 2000;19(11):2580\u201391.","journal-title":"EMBO J"},{"issue":"1","key":"2728_CR27","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/s41467-018-03716-9","volume":"9","author":"B Zhang","year":"2018","unstructured":"Zhang B, et al. TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-kappaB signaling. Nat Commun. 2018;9(1):1423.","journal-title":"Nat Commun"},{"issue":"3","key":"2728_CR28","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1002\/mco2.502","volume":"5","author":"J Xie","year":"2024","unstructured":"Xie J, et al. Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer. MedComm. 2024;5(3):e502.","journal-title":"MedComm"},{"issue":"3","key":"2728_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","volume":"26","author":"MS Hayden","year":"2012","unstructured":"Hayden MS, Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012;26(3):203\u201334.","journal-title":"Genes Dev"},{"issue":"11","key":"2728_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nri2423","volume":"8","author":"S Ghosh","year":"2008","unstructured":"Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 2008;8(11):837\u201348.","journal-title":"Nat Rev Immunol"},{"issue":"4878","key":"2728_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1126\/science.3140380","volume":"242","author":"PA Baeuerle","year":"1988","unstructured":"Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988;242(4878):540\u20136.","journal-title":"Science"},{"issue":"5103","key":"2728_CR32","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.8096091","volume":"259","author":"SC Sun","year":"1993","unstructured":"Sun SC, et al. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science. 1993;259(5103):1912\u20135.","journal-title":"Science"},{"issue":"2","key":"2728_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, et al. The ClusPro web server for protein-protein docking. Nat Protoc. 2017;12(2):255\u201378.","journal-title":"Nat Protoc"},{"issue":"W1","key":"2728_CR34","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296\u2013303.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02728-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:55:35Z","timestamp":1774518935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02728-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2728"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02728-z","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}